ReviewBMC surgery2026
Axillary desmoid-type fibromatosis: a rare clinical presentation, histopathological correlation, and literature review.
Review in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDesmoid tumours are rare soft-tissue tumours arising from mesenchymal tissue and exhibiting local invasiveness, although they don't metastasize. These tumours present variably and follow an unpredictable course, ranging from asymptomatic to locally aggressive with excruciating symptoms. Surgical intervention is indicated for symptomatic cases, while indolent cases benefit from close surveillance. Recently, the use of systemic approaches to the management of desmoid tumours has increased. These include γ-secretase inhibitors, which have shown encouraging therapeutic results in the treatment of progressive, refractory cases. Nonetheless, due to the disease's rarity, managing DT remains challenging, and updating the field with current knowledge is warranted. Our case presents a rare axillary desmoid tumour, for which surgical resection was chosen and optimized to achieve complete clearance while preserving upper-limb function. CASE PRESENTATION: Herein, we present a rare case of desmoid-type fibromatosis in the right axillary region of a young, otherwise healthy female. Surgical resection of the mass was performed without intra- or postoperative complications, with the aim of preserving upper-limb function and motion. Postoperative follow-up over 18 months showed no clinical or radiological evidence of tumour recurrence, with full preservation of upper-limb function and motion.
conclusionDesmoid tumours of the axilla are clinically challenging, requiring a careful balance between complete resection and functional preservation. Recently, active surveillance has been used as the primary management for desmoid tumour cases and has shown spontaneous regression without the need for intervention. However, our case demonstrates that a surgical approach can still achieve excellent local control and long-term disease-free survival without functional impairment. It also provides live evidence underscoring the valuable role of surgery in managing symptomatic or progressive tumours in complex anatomical locations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.